Randomized Trialhigh evidence
Cytisinicline for 6 or 12 wk increased smoking cessation rates after treatment and up to 24 wk.
Annals of internal medicine·September 1, 2025·PMID 40889365
Why it mattersCytisinicline offers a potential new pharmacotherapy option for smoking cessation, which is relevant for pain specialists managing patients where smoking worsens outcomes and complicates treatment.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled